文献速递银屑病与炎症性皮肤病

英国生物银行与HUNT研究中银屑病相关循环代谢物:470352例横断面分析

Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 470,352 participants.
PubMed 文献 · Br J Dermatol · 2026-03-30

该研究基于英国生物银行(n=453428)和HUNT(n=16924)共470352名白人/欧洲个体的横断面数据,用核磁共振波谱定量代谢物。完全校正后仅GlycA与银屑病相关(UKB系数0.09,95%CI 0.07-0.11;HUNT 0.11,95%CI 0.06-0.17),银屑病关节炎中苯丙氨酸显著升高,银屑病代谢谱与其他免疫介导炎性疾病不同。

要点

  • 完全校正后仅GlycA与银屑病独立相关,提示其作为系统性炎症标志物的潜力。
  • 银屑病关节炎患者苯丙氨酸水平显著高于皮肤局限型银屑病。
  • 银屑病代谢谱与其他免疫介导炎性疾病不同,支持其独特系统性特征。

核心结论

  • 大规模研究证实银屑病患者存在代谢改变,苯丙氨酸可能是关节受累的潜在生物标志物。
  • 银屑病相对其他免疫介导炎性疾病的独特代谢谱提示其可能具有独特的系统性特征。

研究设计与样本

  • 横断面分析,纳入英国生物银行453428例和HUNT 16924例白人/欧洲个体,共470352例。
  • 采用核磁共振波谱定量代谢物,涵盖脂蛋白组分与亚组分、脂肪酸和小分子代谢物。
  • 对每个代谢物进行多变量线性回归,校正年龄、性别、BMI、吸烟状态和降脂药物使用。

主要发现

  • 年龄和性别校正模型中,123项代谢指标与银屑病相关。
  • 完全校正后,仅GlycA仍与银屑病相关:英国生物银行系数0.09(95%CI 0.07-0.11),HUNT 0.11(95%CI 0.06-0.17)。
  • HUNT中重度银屑病较非重度银屑病表现出更明显的代谢改变。
  • 两队列中银屑病关节炎患者苯丙氨酸水平均显著高于皮肤型银屑病:英国生物银行0.44(95%CI 0.29-0.60),HUNT 0.47(95%CI 0.28-0.67)。
  • 跨免疫介导炎性疾病比较中,特应性皮炎和皮肤局限型银屑病代谢改变较轻,HUNT银屑病显示独特脂蛋白谱。

临床怎么用

  • GlycA可作为银屑病系统性炎症的候选生物标志物,但需进一步验证。
  • 苯丙氨酸可能有助于识别银屑病关节受累,可考虑纳入关节炎筛查研究。
  • 评估银屑病患者代谢共病时,应意识到其代谢谱与其他免疫介导炎性疾病不同。

局限性

  • 横断面设计无法推断代谢改变与银屑病的因果关系。
  • 研究人群为白人/欧洲个体,结果外推至其他种族需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is recognized as a systemic inflammatory disease associated with metabolic dysregulation. Understanding these metabolic changes may reveal biomarkers to elucidate disease mechanisms and predict comorbidities. While previous studies have identified psoriasis-associated metabolites, findings are often limited by sample sizes and lack validation. OBJECTIVES: To identify circulating metabolites associated with psoriasis, including disease severity and psoriatic arthritis. Further, we investigated whether the metabolic signature was disease-specific compared to other immune-mediated inflammatory diseases (IMIDs). METHODS: We performed a cross-sectional analysis of 470,352 White/European individuals from the UK Biobank (n=453,428) and HUNT (n=16,924). Nuclear Magnetic Resonance spectroscopy was used to quantify metabolite levels, covering lipoprotein fractions and subfractions, fatty acids, and small-molecular metabolites. For each metabolite, we performed multivariable linear regression adjusting for age, sex, BMI, smoking status, and use of lipid-lowering medications. RESULTS: The metabolomic profile of psoriasis was largely consistent across the two populations. In the model adjusted for age and sex, 123 metabolic measures were associated with psoriasis. After full adjustment, only Glycoprotein acetyls (GlycA) remained associated with psoriasis (coefficient [95% CI]: 0.09 [0.07-0.11] in UK Biobank and 0.11 [0.06-0.17] in HUNT). In HUNT, severe psoriasis exhibited more pronounced metabolic alterations compared to non-severe psoriasis. Across both populations, phenylalanine levels were highly elevated in psoriatic arthritis compared to cutaneous psoriasis (0.44 [0.29-0.60] in UK Biobank and 0.47 [0.28-0.67] in HUNT). In comparisons across IMIDs, atopic dermatitis and cutaneous-limited psoriasis exhibited milder metabolic alterations, and psoriasis in HUNT showed a distinct lipoprotein profile. CONCLUSIONS: This large-scale study confirms metabolic alterations in individuals with psoriasis and highlights phenylalanine as a potential biomarker for joint involvement in psoriasis. The distinct metabolomic profile of psoriasis relative to other IMIDs suggests a potentially unique systemic profile. These findings offer a foundation for advancing biomarker research and mechanistic studies for psoriasis.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Arham AGA, Sharma A, Thomas LF, et al. Circulating metabolites associated with psoriasis in the UK Biobank and the HUNT Study: A cross-sectional study of 470,352 participants. Br J Dermatol. 2026. PMID: 41911431. doi:10.1093/bjd/ljag116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。